ADAM12 abrogation alters immune cell infiltration and improves response to checkpoint blockade therapy in the T11 murine model of triple-negative breast cancer

Volume 12, Issue 1, December 2023 .

Source: OncoImmunology - December 16, 2022 Category: Cancer & Oncology Authors: Guanpeng Wang Yeni Romero Indhujah Thevarajan Anna Zolkiewska Source Type: research